• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能建立 PSC 的模型吗?- “成为 PSC 的模型太难了!”。

Will we ever model PSC? - "it's hard to be a PSC model!".

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

出版信息

Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):792-804. doi: 10.1016/j.clinre.2011.04.014. Epub 2011 Jun 23.

DOI:10.1016/j.clinre.2011.04.014
PMID:21703962
Abstract

Cholangiopathies such as primary sclerosing cholangitis (PSC) represent an important group of liver diseases of the intra- and extrahepatic bile ducts frequently causing end-stage liver disease with significant morbidity and mortality due to limited treatment options. The relatively low incidence of PSC and the difficult accessibility of the human bile duct system for longitudinal studies may represent some of the critical reasons for the lack of profound knowledge in regard to PSC pathophysiology. Therefore, there is an urgent need for reliable, well-defined and easily reproducible animal models to learn more about the pathophysiology of PSC and to test novel treatment modalities. In an ideal world, immunogenetically predisposed animals would develop fibrous-obliterative cholangitis of the intra- and extrahepatic bile ducts in association with inflammation of the gut (especially colitis) in a highly reproducible manner allowing to test new drugs. To date, however, no such animal model is available. We aimed to provide a systematic overview of current available rodent models for sclerosing cholangitis and biliary fibrosis and therefore critically analyzed the characteristics of models for chemically-induced cholangitis, knock-out mouse models with cholangitis, cholangitis induced by infectious agents, models of experimental biliary obstruction, models involving enteric bacterial cell-wall components or colitis, and models of primary biliary epithelial and endothelial cell injury.

摘要

原发性硬化性胆管炎(PSC)等胆管疾病是一组重要的肝内外胆管疾病,由于治疗选择有限,常导致终末期肝病,发病率和死亡率高。PSC 的发病率相对较低,且人类胆管系统难以进行纵向研究,这可能是导致对 PSC 病理生理学缺乏深入了解的一些关键原因。因此,迫切需要可靠、明确且易于复制的动物模型,以更多地了解 PSC 的病理生理学,并测试新的治疗方法。在理想情况下,免疫遗传易感性动物会以高度可重复的方式发生肝内外胆管纤维性闭塞性胆管炎,并伴有肠道炎症(尤其是结肠炎),从而能够测试新药。然而,到目前为止,还没有这样的动物模型。我们旨在提供当前用于硬化性胆管炎和胆汁性纤维化的啮齿动物模型的系统综述,因此对化学诱导性胆管炎模型、具有胆管炎的基因敲除小鼠模型、感染因子引起的胆管炎、实验性胆道梗阻模型、涉及肠细菌细胞壁成分或结肠炎的模型以及原发性胆汁性上皮和内皮细胞损伤的模型的特征进行了批判性分析。

相似文献

1
Will we ever model PSC? - "it's hard to be a PSC model!".我们能建立 PSC 的模型吗?- “成为 PSC 的模型太难了!”。
Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):792-804. doi: 10.1016/j.clinre.2011.04.014. Epub 2011 Jun 23.
2
Animal models for primary sclerosing cholangitis.原发性硬化性胆管炎的动物模型
Best Pract Res Clin Gastroenterol. 2001 Aug;15(4):591-610. doi: 10.1053/bega.2001.0207.
3
Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.原发性硬化性胆管炎终末期伴或不伴胆管癌的癌前胆管病变。
Am J Surg Pathol. 2010 Jan;34(1):27-34. doi: 10.1097/PAS.0b013e3181bc96f9.
4
Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.儿童期肝脏和胆道自身免疫性疾病及重叠综合征
Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70.
5
Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.原发性硬化性胆管炎的免疫遗传学方面:对治疗策略的影响。
Am J Gastroenterol. 1995 Jun;90(6):893-900.
6
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
7
New insights into autoimmune cholangitis through animal models.通过动物模型深入了解自身免疫性胆管炎。
Dig Dis. 2010;28(1):99-104. doi: 10.1159/000282072. Epub 2010 May 7.
8
Management of primary sclerosing cholangitis.原发性硬化性胆管炎的管理
Minerva Gastroenterol Dietol. 2009 Jun;55(2):163-72.
9
[Autoimmune pancreatitis and IgG-positive sclerosing cholangitis].[自身免疫性胰腺炎与IgG阳性硬化性胆管炎]
Vnitr Lek. 2011 Mar;57(3):254-7.
10
Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.儿童免疫介导性胆管病:为寻找未来可能的治疗靶点,需要更好地了解其病理生理学。
Front Immunol. 2023 Oct 20;14:1206025. doi: 10.3389/fimmu.2023.1206025. eCollection 2023.

引用本文的文献

1
Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction.用于肝脏再生医学和胆管重建的生物工程胆管
JGH Open. 2025 Aug 12;9(8):e70254. doi: 10.1002/jgh3.70254. eCollection 2025 Aug.
2
Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.原发性硬化性胆管炎患者胆管类器官的单细胞转录组分析。
Dig Dis Sci. 2024 Oct;69(10):3810-3823. doi: 10.1007/s10620-024-08570-y. Epub 2024 Aug 19.
3
Effect of Valproic Acid on Promoting the Differentiation of Human Embryonic Stem Cells Into Cholangiocyte-Like Cells.
丙戊酸对促进人胚胎干细胞向胆管细胞样细胞分化的影响。
Stem Cells Transl Med. 2024 Feb 14;13(2):166-176. doi: 10.1093/stcltm/szad079.
4
The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease.自噬蛋白 p62 是人类和鼠类胆汁淤积性肝病中活性醛的靶标。
PLoS One. 2022 Nov 15;17(11):e0276879. doi: 10.1371/journal.pone.0276879. eCollection 2022.
5
Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis.微生物群失调、胆管细胞因子及原发性硬化性胆管炎发病机制研究模型的最新发现
Open Med (Wars). 2022 May 13;17(1):915-929. doi: 10.1515/med-2022-0481. eCollection 2022.
6
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective.慢性肝病中的肠-肝轴:巨噬细胞的视角。
Cells. 2021 Oct 30;10(11):2959. doi: 10.3390/cells10112959.
7
Rodent models of cholestatic liver disease: A practical guide for translational research.胆汁淤积性肝病的啮齿动物模型:转化研究的实用指南。
Liver Int. 2021 Apr;41(4):656-682. doi: 10.1111/liv.14800. Epub 2021 Feb 23.
8
Alagille Syndrome: Diagnostic Challenges and Advances in Management.阿拉吉耶综合征:诊断挑战与治疗进展
Diagnostics (Basel). 2020 Nov 6;10(11):907. doi: 10.3390/diagnostics10110907.
9
Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis.胆汁酸调节联合胆汁淤积和结肠炎小鼠模型结肠 MAdCAM-1 的表达。
Mucosal Immunol. 2021 Mar;14(2):479-490. doi: 10.1038/s41385-020-00347-6. Epub 2020 Oct 1.
10
Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice.胆管结扎诱导的胆汁淤积症促进了小鼠肠道微生物组的变化。
Sci Rep. 2019 Aug 23;9(1):12324. doi: 10.1038/s41598-019-48784-z.